Glycopyrrolate Injection, Solution
Product Images NDC 0404-9777
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0404-9777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
This text seems to provide data on different groups and their responses to certain parameters at various dosages. The groups are labeled based on the administered substance or method (IV or IM). The parameters included are tin, Vs, Ccl, Tmax, Cmax, and AUC. Dosages of 6ug/kg IV and 8pg/kg IM appear to have been administered to these groups, with corresponding measurements and values recorded. Analysis and comparison of these results may yield insights into the effects of the substances on the groups studied.*
Image2.jpg (Image2)
Label1.jpg (Label1)
This text is a label describing a 0.2 mg/mL injection, USP contained in a 20mL multiple-dose vial. The injection is suitable for intramuscular or intravenous administration but is not meant for newborns due to the presence of benzyl alcohol. It should be stored at room temperature between 20°C and 26°C. The manufacturing information indicates that it was packaged by Henry Schein, Inc. and provides additional lot and expiration details. The label also features item and lot numbers for tracking purposes, along with safety instructions such as keeping it out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.